Omada Health, Inc. (OMDA) Income Statement
OMDA 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsOMDA revenue and net income
Where OMDA's revenue goes
2025Each bar shows an amount and its share of revenue. OMDA kept −4.9% of revenue as net income.
OMDA profit margins
OMDA growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +53.2% | +42.9% | — | — |
| Gross profit | +66.2% | +58.7% | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
OMDA quarterly EPS vs estimates
Omada Health beat the analyst EPS estimate in 4 of the last 6 quarters. Next report: November 5, 2026 (estimate $0.01).
OMDA income statement
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $260.2M | $169.8M | $122.8M | $89.2M |
| Cost of revenue | $89.3M | $66.9M | $52.8M | $46.4M |
| Gross profit | $170.9M | $102.9M | $70.0M | $42.8M |
| Research & development | $40.7M | $35.9M | $33.7M | $26.2M |
| Sales, general & admin | $142.2M | $110.6M | $102.2M | $89.0M |
| Total operating expenses | $182.9M | $146.5M | $136.0M | $115.1M |
| Operating income | −$12.0M | −$43.7M | −$66.0M | −$72.3M |
| Interest income | $5.3M | $805,000 | $5.8M | $2.2M |
| Interest expense | $2.5M | $4.5M | $4.7M | $4.2M |
| Income before taxes | −$12.8M | −$47.1M | −$67.5M | −$72.5M |
| Net income | −$12.8M | −$47.1M | −$67.5M | −$72.5M |
| EBITDA | −$4.8M | −$37.8M | −$58.4M | −$64.0M |
| EPS (diluted) | −$0.16 | −$0.85 | −$1.21 | — |
| Gross margin | 65.7% | 60.6% | 57.0% | 48.0% |
| Operating margin | −4.6% | −25.7% | −53.8% | −81.1% |
| Net margin | −4.9% | −27.8% | −55.0% | −81.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $87.8M | $78.0M | $75.8M | $68.0M | $61.4M | $55.0M | $48.0M | $45.5M | $41.2M | $35.1M | $32.5M | $32.9M |
| Cost of revenue | $24.0M | $29.4M | $22.2M | $23.0M | $21.2M | $23.1M | $16.0M | $17.1M | $16.5M | $17.7M | $12.4M | $12.9M |
| Gross profit | $63.8M | $48.7M | $53.7M | $45.1M | $40.2M | $31.9M | $32.0M | $28.4M | $24.7M | $17.3M | $20.1M | $20.1M |
| Research & development | $14.6M | $739,000 | $11.6M | $10.3M | $10.0M | $8.8M | $9.2M | $8.8M | $9.0M | $8.9M | $8.5M | $8.3M |
| Sales, general & admin | $45.6M | $3.4M | $38.8M | $37.3M | $34.5M | $31.5M | — | — | $25.9M | $26.4M | — | — |
| Total operating expenses | $60.2M | $53.5M | $50.4M | $47.6M | $44.5M | $40.3M | $39.1M | $36.9M | $34.7M | $35.3M | $33.5M | $34.0M |
| Operating income | $3.5M | −$4.8M | $3.3M | −$2.5M | −$4.3M | −$8.4M | −$7.1M | −$8.5M | −$10.0M | −$18.0M | −$13.4M | −$14.0M |
| Interest income | $1.8M | $1.8M | $1.9M | $2.0M | $863,000 | $542,000 | — | — | $85,000 | $529,000 | — | — |
| Interest expense | $14,000 | $18,000 | $13,000 | $353,000 | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.2M |
| Income before taxes | $5.3M | −$3.0M | $5.2M | −$3.2M | −$5.3M | −$9.4M | −$8.2M | −$9.2M | −$10.7M | −$19.0M | −$13.9M | −$14.0M |
| Net income | $5.3M | −$3.0M | $5.2M | −$3.2M | −$5.3M | −$9.4M | −$8.2M | −$9.2M | −$10.7M | −$19.0M | −$13.9M | −$14.0M |
| EBITDA | $6.9M | −$1.4M | $6.6M | −$1.8M | −$2.9M | −$7.0M | −$5.9M | −$6.9M | −$8.4M | −$16.7M | −$11.7M | −$11.7M |
| EPS (diluted) | $0.08 | $0.05 | $0.16 | $0.03 | −$0.22 | −$0.13 | — | — | — | — | — | — |
| Gross margin | 72.6% | 62.4% | 70.8% | 66.3% | 65.5% | 58.0% | 66.6% | 62.4% | 59.9% | 49.4% | 61.7% | 60.9% |
| Operating margin | 4.0% | −6.1% | 4.3% | −3.7% | −7.1% | −15.3% | −14.8% | −18.7% | −24.4% | −51.3% | −41.2% | −42.4% |
| Net margin | 6.0% | −3.8% | 6.8% | −4.7% | −8.7% | −17.2% | −17.2% | −20.3% | −25.9% | −54.1% | −42.8% | −42.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in OMDA's financial statements (latest annual report filed March 6, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
OMDA financial results
In fiscal year 2025 (ended December 31, 2025), Omada Health reported revenue of $260.2 million, up 53.2% from the year before. It had a net loss of $12.8 million, a net profit margin of −4.9%. Diluted earnings per share came to −$0.16.
See the OMDA stock overview for the latest quote and news, or the OMDA chart for price history and technical indicators.
OMDA income statement FAQ
What is Omada Health's annual revenue?
Omada Health reported total revenue of $260.2 million for fiscal year 2025, which ended on December 31, 2025. That was up 53.2% from $169.8 million the previous year.
Is Omada Health profitable?
No. Omada Health reported a net loss of $12.8 million in fiscal 2025, a net profit margin of −4.9%; its operating margin was −4.6%.
What is Omada Health's gross margin?
Omada Health's gross margin was 65.7% in fiscal 2025: for every $100 of revenue, Omada Health kept $66 after the direct cost of its products and services.
How much does Omada Health spend on research and development?
Omada Health spent $40.7 million on research and development in fiscal 2025, 15.6% of revenue.
What are Omada Health's earnings per share?
Omada Health earned $-0.16 per diluted share in fiscal 2025, compared with $-0.85 a year earlier.
When will Omada Health report its next earnings?
Omada Health is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes.
When does Omada Health's fiscal year end?
Omada Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 6, 2026.